Scientific Sessions
Scientific Sessions
  • Program
  • #AHA24
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA24
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 20th, 2024

AI medical company wins global health tech competition at #AHA24

Two companies recognized in the 2024 Health Tech Competition.


Health Tech winners
Left to right: AHA CEO Nancy Brown, Felix Bauer, Powerful Medical COO, Martin Herman, Powerful Medical CEO, Robert Herman, MD, Powerful Medical chief medical officer, and Star Jones, lawyer/TV personality and AHA national volunteer.

While major advances are being made in prevention of cardiovascular disease and stroke, which affects nearly 50% of adults in the U.S., experts urge new solutions to put these innovations in the hands of Americans and apply them to their daily habits. The American Heart Association Center for Health Technology & Innovation named Powerful Medical of New York the overall winner of its annual Health Tech Competition during Scientific Sessions 2024, as well as the winner of the Science subcategory. HekaHeart of San Mateo, California, was named the winner of the Business category.

The annual Health Tech Competition offers a live forum for health care technology start-up companies to showcase innovative solutions for treating and preventing cardiovascular diseases and stroke. Winning ideas involve, engage or support patient treatment and solve a pervasive problem in antithrombotic, coronary artery disease/acute coronary syndrome, cardiovascular kidney metabolic syndrome, cardiometabolic, electrophysiology, heart failure, hypertension, imaging, lipids, resuscitation, stroke, surgery or vascular medicine. The Health Tech Competition is supported financially by the Laerdal Million Lives Fund and produced by the AHA.

The 2024 winner of the Health Tech Competition, Powerful Medical, seeks to augment physicians and care teams in diagnosis and treatment of cardiovascular diseases using AI tools.

“At the moment, our focus is heart attack diagnostics as the number one killer, but it’s just a start for us,” said Martin Herman, Powerful Medical CEO.

This innovative technology was selected as the winner based on the validity of the working prototype, scientific rigor and potential impact on patient outcomes.

Finalists offered solutions featuring novel technological solutions to cardiovascular health issues such as heart failure, pulmonary embolism, and others. Powerful Medical was chosen as the winner based on their potential health impact, business and technology promise and scientific evidence as judged by panels of AHA volunteers, industry experts and scientific community.  

A panel of expert volunteer judges also selected HekaHeart as the best business pitch, opening opportunities for them to connect with scientific and business leaders after Scientific Sessions. As a guideline-directed medical therapy-led heart failure clinic focused on optimizing virtual medical visits, HekaHeart helps cardiology groups and health systems optimize patient outcomes, reduce clinician burden and improve financial performance through medication optimization and volume management.

Powerful Medical and HekaHeart will receive membership to the Center for Health Technology & Innovation Innovators’ Network, a consortium that connects entrepreneurs, providers, researchers and payers to advance innovation in cardiovascular and brain health. Innovators' Network members also have the opportunity to access the association's digital evidence-based scientific guidelines and clinical recommendations as they develop digital health care technologies. 

Interesting Stories
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
More Content
241116 American Heart Association Keynote 0080
AHA24
LBS 08: Advances in lipid therapeutics
Nov 20th, 2024
Crowd shot
AHA24
LBS 07: New approaches to managing AFib
Nov 20th, 2024
Stage shot
AHA24
LBS 06: Medical therapy for heart failure
Nov 20th, 2024
Stage shot
AHA24
LBS 05: Innovation in prevention
Nov 20th, 2024
French Quarter balcony shot
AHA24
Save the date for #AHA25 in New Orleans
Nov 20th, 2024
Asgar headshot
AHA24
Managing patients with symptomatic mitral or tricuspid regurgitation
Nov 18th, 2024
Nancy Brown headshot
AHA24
AHA CEO: Driving breakthroughs
Nov 18th, 2024
Shot of speakers
AHA24
Environmental crises call for more CV research
Nov 18th, 2024
Churchwell
AHA24
Wake-up call: Heeding global risk factors
Nov 18th, 2024
Aha24 Nejm Web Image
AHA24
Streamlining the pathway to publish cardiovascular research
Nov 18th, 2024
Casadei headshot
AHA24
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Nov 18th, 2024
Stage shot
AHA24
LBS 04: Coronary and valvular heart disease
Nov 18th, 2024